Evogene (NASDAQ:EVGN) Now Covered by StockNews.com
StockNews.com began coverage on shares of Evogene (NASDAQ:EVGN – Free Report) in a research note published on Sunday. The firm issued a sell rating on the biotechnology company’s stock. Evogene Price Performance Shares of NASDAQ EVGN opened at $1.46 on Friday. Evogene has a one year low of $1.20 and a one year high of […]
